Ben-Gurion University researchers developing new probiotic yogurt-based drugs for inflammatory conditions and bacteria

摘要

RESEARCHERS AT BEN-GURION UNIVERSITY of the Negev (BGU) have for the first time identified new drug candidates based on molecules isolated from probiotic Kefir yogurt to combat pathogenic bacteria and treat various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19 related cytokine storms.The research, published in Microbiome, a leading peer-reviewed publication was led by Orit Malka, a Ph.D. student of Prof. Raz Jelinek, BCU vice president and dean for research and development.